The National Attorneys General Training & Research Institute
Promising & Best Practices Report
- Jay Butler, MD, CPE, ASTHO President, Chief Medical Officer, Alaska Department of Health and Social Services, and Director, Division of Public Health
- Michael Fraser, PhD, CAE, ASTHO Executive Director
- Peter Kilmartin, Rhode Island Attorney General
- Greg Zoeller, Indiana Attorney General
Keynote Speaker: Michael Botticelli, Director, Office of National Drug Control Policy (ONDCP)
Legal and Public Health Landscape: The Opioid Epidemic and Opportunities for State and Federal Engagement
The panel laid the foundation for topics discussed during the Summit by noting the historical and current landscape of the opioid epidemic, opportunities for engagement, and why collective partnerships and collaboration are critical to resolving the crisis.
MODERATOR: Michael Fraser, PhD, CAE, ASTHO Executive Director
- Jay Butler, MD,CPE, ASTHO President, Chief Medical Officer, Alaska Department of Health and Social Services, and Director, Division of Public Health
- Nicholas E. Hagemeier, PharmD, PhD, Assistant Professor, Department of Pharmacy Practice, East Tennessee State University
- Peter Kilmartin, Rhode Island Attorney General
- Jack Stein, PhD, Director, Office of Science Policy and Communications, National Institute on Drug Abuse, National Institutes of Health, U.S. Department of Health and Human Services
Federal and State Policy Solutions to the Opioid Epidemic
The panel will describe various state models and approaches that have been utilized to lessen the destructive effects and impact of the opioid epidemic from a medical, policy, and law enforcement standpoint. Suggested best practices on policymaking will be shared.
MODERATOR: James Cantor, Chief Deputy Attorney General, Alaska Attorney General's Office
- Terry Cline, PhD, Oklahoma Commissioner of Health, Oklahoma State Department of Health
- Joanna Lydgate, Deputy Attorney General, Massachusetts Attorney General’s Office
- Shawn Mullen, Supervisory Special Agent, New York Health Care Fraud Task Force, Federal Bureau of Investigation
Keynote Speaker: Dr. Vivek H. Murthy, U.S. Surgeon General
Opioid Prevention, Education, and Outreach Campaigns
The panel will focus on outreach and public awareness campaigns aimed at informing the public’s most vulnerable populations while simultaneously providing resources to those in need of treatment services.
MODERATOR: Greg Zoeller, Indiana Attorney General
- Monica Bharel, MD, MPH, Commissioner, Massachusetts Department of Public Health
- Jennifer Biddinger, Director of Drug Abuse Outreach Initiatives, Ohio Attorney General’s Office
- Kristen Kelley, Rx Drug Task Force Coordinator, Indiana Attorney General’s Office
Keynote Speaker: Kana Enomoto, Principal Deputy Administrator, Substance Abuse and Mental Health Services Administration (SAMHSA)
Confronting the Reality of Opioid Use, Misuse, and Treatment
The panel will provide an honest portrayal noting the impact that opioid use disorders have for those suffering from addiction, in recovery, and the resulting medical ailments that commonly affect users. Information will be offered on which services and outreach efforts tend to encourage receipt of treatment services, allowing for a successful road to recovery.
- Centers for Disease Control and Prevention - Additional Resources on HIV Prevention and County Assessment of Opioids Impact on HIV
MODERATOR: Robert Morrison, Executive Director/Director of Legislative Affairs, National Association of State Alcohol and Drug Abuse Directors (NASADAD)
- Yavar Moghimi, MD, Psychiatrist, Whitman-Walker Health
- Rebecca B. Parker, MD, FACEP, President, American College of Emergency Physicians and Attending Emergency Physician, West Suburban Medical Center, Oak Park, Ill.
- Kellie Robinson, CSA/AD, Person in Recovery, Addiction Counselor, University of Maryland
- Eric Triana, Acting Unit Chief, Coordination and Support Unit (DOPC), Pharmaceutical Investigations Section (DOP), Diversion Control Division (DO), U.S. Department of Justice (DOJ)
Parallel Responsibilities of Prescribers and Dispensers
The panel will examine corresponding responsibilities for prescribers and dispensers from those in the medical, pharmaceutical, legal, and public health disciplines. Recommendations will be shared on how best to identify the requisite duties of prescribers and dispensers in ever-evolving times and how the opioid epidemic conversation has progressed.
MODERATOR: Brad Schimel, Wisconsin Attorney General
- Daniel Blaney-Koen, Senior Legislative Attorney, American Medical Association
- Harry Chen, MD, Commissioner, Vermont Department of Health
- Anna Legreid Dopp, PharmD, Director, Clinical Guidelines and Quality Improvement, Center on Medication Safety and Quality, American Society of Health-System Pharmacists
- Christopher Jones, PharmD, MPH, CDR, U.S. Public Health Service, Director, Division of Science Policy, Office of the Assistant Secretary for Planning and Evaluation, U.S. Department of Health and Human Services
Keynote Speaker: Chuck Rosenberg, Acting Administrator, Drug Enforcement Administration, U.S. Department of Justice
Identifying and Navigating Medical-Legal Challenges for Chronic Pain Patients
The panel will explore the various interdisciplinary approaches needed to address the illegal use of opioids, treatment of chronic pain as an alternative to opioid use, and the resulting benefits and challenges of opioid prescriptions. The panel also will discuss current prescription drug monitoring programs and their ability to lessen the impact of the epidemic.
MODERATOR: Pam Bondi, Florida Attorney General and Substance Abuse Committee Co-Chair, National Association of Attorneys General (NAAG)
- Peggy Compton, RN, PhD, FAAN, Professor, Associate Dean for Research, Evaluation and Graduate Programs, and Interim Chair, Department of Advanced Nursing Practice, Georgetown University School of Nursing & Health Studies
- Lainie Rutkow, JD, PhD, MPH, Associate Professor, Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health
- Bob Twillman, PhD, FAPM, Executive Director, Academy of Integrative Pain Management
Prevention of Overdose Mortality
The panel will discuss techniques and strategies that should be considered during policy deliberations to help prevent the significant number of overdoses and deaths by overdose nationally. Evidence-based and promising practices on collaborative and innovative medical and law enforcement tactics also will be presented.
MODERATOR: Debra Houry, MD, Director, National Center for Injury Prevention and Control (NCIPC), Centers for Disease Control and Prevention (CDC)
- Wilson Compton, MD, MPE, Deputy Director, National Institute on Drug Abuse (NIDA), National Institutes of Health, U.S. Department of Health and Human Services
- Chauncey Parker, Director of the New York/New Jersey High-Intensity Drug Trafficking Area (HIDTA), and Executive Assistant District Attorney and Special Policy Advisor for Crime Strategies, Manhattan District Attorney’s Office
Opioid Prescription Guidelines
The panel will provide an overview on the creation and distribution of guidelines and principles set forth by the Centers for Disease Control and Prevention. Particular attention will be given to how states and practitioners may form, implement, or incorporate guidelines into policymaking aimed at creating effective solutions to address opioid misuse and addiction.
MODERATOR: Joseph Foster, New Hampshire Attorney General